3 results
Approved WMORecruiting
The objective of the study is to compare conventional therapy with biological therapy in patients with early rheumatoid arthritis.
Approved WMORecruiting
The objective of the study is to assess the long-term safety and efficacy of intravenous ATB200 co-administration with oral AT2221 in adult subjects with late-onset Pompe disease.
Approved WMOPending
The primary efficacy objective for this study is to demonstrate non-inferiority of ocrelizumab compared with fingolimod